These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26944192)

  • 1. Rapid emergence of high-level tigecycline resistance in Escherichia coli strains harbouring blaNDM-5 in vivo.
    Li X; Mu X; Yang Y; Hua X; Yang Q; Wang N; Du X; Ruan Z; Shen X; Yu Y
    Int J Antimicrob Agents; 2016 Apr; 47(4):324-7. PubMed ID: 26944192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and fitness costs of tigecycline resistance in Escherichia coli.
    Linkevicius M; Sandegren L; Andersson DI
    J Antimicrob Chemother; 2013 Dec; 68(12):2809-19. PubMed ID: 23843301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt.
    Mohamed NM; Youssef AA
    Microb Drug Resist; 2011 Dec; 17(4):489-95. PubMed ID: 21875338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
    Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of clinical resistance to tigecycline.
    Sun Y; Cai Y; Liu X; Bai N; Liang B; Wang R
    Int J Antimicrob Agents; 2013 Feb; 41(2):110-6. PubMed ID: 23127485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility.
    Roy S; Datta S; Viswanathan R; Singh AK; Basu S
    J Antimicrob Chemother; 2013 May; 68(5):1036-42. PubMed ID: 23335112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
    Tuckman M; Petersen PJ; Howe AY; Orlowski M; Mullen S; Chan K; Bradford PA; Jones CH
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3205-11. PubMed ID: 17620376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tandem amplification of a plasmid-borne tet(A) variant gene confers tigecycline resistance in Escherichia coli.
    Zou C; Xu C; Yu R; Shan X; Schwarz S; Li D; Du XD
    J Antimicrob Chemother; 2024 Jun; 79(6):1294-1302. PubMed ID: 38574003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium.
    Cattoir V; Isnard C; Cosquer T; Odhiambo A; Bucquet F; Guérin F; Giard JC
    Antimicrob Agents Chemother; 2015 Jan; 59(1):239-44. PubMed ID: 25348531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.
    Docobo-Pérez F; Nordmann P; Domínguez-Herrera J; López-Rojas R; Smani Y; Poirel L; Pachón J
    Int J Antimicrob Agents; 2012 Mar; 39(3):251-4. PubMed ID: 22154856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
    Garau J
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.
    Vingopoulou EI; Siarkou VI; Batzias G; Kaltsogianni F; Sianou E; Tzavaras I; Koutinas A; Saridomichelakis MN; Sofianou D; Tzelepi E; Miriagou V
    J Antimicrob Chemother; 2014 Aug; 69(8):2076-80. PubMed ID: 24722836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletions in a ribosomal protein-coding gene are associated with tigecycline resistance in Enterococcus faecium.
    Niebel M; Quick J; Prieto AM; Hill RL; Pike R; Huber D; David M; Hornsey M; Wareham D; Oppenheim B; Woodford N; van Schaik W; Loman N
    Int J Antimicrob Agents; 2015 Nov; 46(5):572-5. PubMed ID: 26364847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fitness of Escherichia coli mutants with reduced susceptibility to tigecycline.
    Linkevicius M; Anderssen JM; Sandegren L; Andersson DI
    J Antimicrob Chemother; 2016 May; 71(5):1307-13. PubMed ID: 26851608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R
    Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii.
    Dizbay M; Tozlu DK; Cirak MY; Isik Y; Ozdemir K; Arman D
    J Antibiot (Tokyo); 2010 Feb; 63(2):51-3. PubMed ID: 19942947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro.
    Hao Q; Wang H; Wang J; Dou J; Zhang M; Zhou W; Zhou C
    J Pept Sci; 2013 Mar; 19(3):173-80. PubMed ID: 23389882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy.
    Giacobbe DR; Del Bono V; Coppo E; Marchese A; Viscoli C
    Microb Drug Resist; 2015 Jun; 21(3):342-4. PubMed ID: 25514440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis.
    Stone NR; Woodford N; Livermore DM; Howard J; Pike R; Mushtaq S; Perry C; Hopkins S
    J Antimicrob Chemother; 2011 Nov; 66(11):2677-8. PubMed ID: 21846669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.